奥氮平改善老年痴呆患者精神行为障碍的临床效果

Abstract
Figure/Table
References (20)
Related Citation (9)

Download: PDF (0 KB) HTML (45 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To observe the clinical effect of Olanzapine in improving mental and behavioral disorder in patients with senile dementia.Methods A total of 114 patients with senile dementia accompanied with mental and behavioral disorder treated by the Fourth People′s Hospital of Jingdezhen from January 2016 to October 2017 were selected and they were divided into the control group and observation group,and there were 57 cases in each group.The control group was treated with Risperidone,while the observation group was treated with Olanzapine.After 8 weeks of continuous drug use,the clinical effect between the two groups was compared.Results The total effective rate of the observation group was 92.98%,while that of the control group was 89.47%,and there was no significant difference between the two groups(P＞0.05).At 2,4 and 8 weeks after treatment,the BEHAVE-AD score of the patients in the observation group was(18.0±4.4),(10.1±3.8)and (7.0±3.3)points respectively,which were lower than those of the control group ([20.2±4.5],[13.7±4.0],[8.6±3.8]points)and before treatment([23.2±5.2])points,and the differences were statistically significant(P＜0.05).In patients of the control group,the BEHAVE-AD score at 2,4 and 8 weeks after treatment were all lower than those before treatment([22.9±5.0])points,and the differences were statistically significant(P＜0.05).The incidence of abnormal liver function,lethargy and fatigue after treatment in the observation group was 1.75%,8.77%and 7.02%respectively,and the control groups was 0.00,7.02%and 3.51%respectively,and there was no significant difference between the two groups(P＞0.05).The incidence of irritation,extrapyramidal reaction and insomnia in the observation group was 0.00,3.51%,1.75%respectively,which were lower than those of the control group(8.77%and 19.30%.14.04%)(P＜0.05),and the total incidence of side effect in the observation group was 22.81%,which was lower than that of the control group(52.63%),and the difference was statistically significant(P＜0.05).The ADL score of the observation group after treatment was(37.1±7.0)points,which was lower than that of the control group([40.7±8.5]points),and the difference was statistically significant(P＜0.05).Conclusion Olanzapine treating senile dementia accompanied with mental and behavioral disorder can effectively improve the pathological behavior of patients with Alzheimer disease,with significant clinical effect,fewer side effects and high safety.It is worthy of clinical promotion.

Key words： Senile dementia Mental behavior disorder Olanzapine Risperidone

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	FENG Chun-yan

Cite this article:

FENG Chun-yan. Clinical effect of Olanzapine in improving mental and behavioral disorder in patients with senile dementia[J]. 中国当代医药, 2018, 25(19): 20-23.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2018/V25/I19/20

[1]	王春雨，储华.奥氮平治疗老年痴呆伴发精神行为障碍临床研究[J].中国民康医学，2010，22（15）：1972-1973.
[2]	魏娟，谢江涛，武兴兴，等.奥氮平治疗对改善老年痴呆精神行为障碍的临床疗效分析[J].国际精神病学杂志，2015，42（6）：41-44.
[3]	沈燕萍.六味地黄丸和奥氮平对老年痴呆精神行为症状改善作用的比较[J].中医药导报，2013，19（12）：39-41.
[4]	中华医学会精神科分会.CCMD-3中国精神障碍分类与诊断标准[M].济南：山东科学技术出版社，2001：37-40.
[5]	李志民，金燕.喹硫平、奥氮平用于老年痴呆患者精神行为障碍治疗研究[J].维吾尔医药月刊，2013，23（4）：6039-6040.
[6]	廖波，李彦，唐宁，等.重复经颅磁刺激治疗老年痴呆精神行为症状的效果评估及研究[J].中国医学创新，2017，14（34）：21-24.
[7]	苏志诚，褚克丹，阮时宝，等.探讨老年痴呆症发病风险评估量表的设计[J].中国医学创新，2017，14（11）：116-120.
[8]	曾彦，廖佳隆，谢春辉.盐酸多奈哌齐治疗老年痴呆的效果[J].中国当代医药，2017，24（24）：72-74.
[9]	王礼群，唐菊艳.喹硫平、奥氮平用于老年痴呆患者精神行为障碍治疗研究[J].维吾尔医药月刊，2013，23（4）：6039-6040.
[10]	熊飞东.奥氮平治疗老年痴呆精神行为障碍的临床效果观察[J].河南医学研究，2017，26（11）：2036-2037.
[11]	吕海波，甘收云.头部穴位透刺疗法配合自拟培元开窍汤加减治疗阿尔茨海默病的效果[J].中国当代医药，2017，24（22）：135-138.
[12]	齐雪丹，许凡宇，范炤.轻度认知障碍及阿尔茨海默病的sMRI分析[J].中国当代医药，2017，24（8）：9-13.
[13]	徐海，范玲，白帆，等.多奈哌齐联合奥氮平治疗老年痴呆精神行为障碍的随机对照研究[J].国际精神病学杂志，2015，42（2）：6-8.
[14]	黄文平，赵祖安，白玉红，等.奥氮平与利培酮治疗痴呆患者精神行为症状的对照研究[J].中国医药导报，2012，9（25）：102-104.
[15]	梁月兰，文国强.奥氮平治疗老年痴呆伴发精神行为障碍临床观察[J].实用临床医药杂志，2015，19（s1）：88.
[16]	古淑敏，陈非，曹国兴.美金刚联合奥氮平治疗伴发精神行为症状的老年痴呆临床研究[J].中国药业，2017，26（4）：46-49.
[17]	唐芸.盐酸美金刚片联合多奈哌齐治疗老年痴呆的临床疗效观察[J].中国现代医生，2017，55（35）：111-113.
[18]	张俊芳，陈钦健，梁丽梅.3种方案治疗老年痴呆精神行为障碍的成本-效果分析[J].中国医院药学杂志，2011，31（12）：1037-1038.
[19]	蔡鸣，马强，高平，等.奥氮平与利培酮治疗老年性痴呆精神行为症状的临床对比分析[J].中国老年学杂志，2011，31（10）：1772-1773.
[20]	蔡旭明.奥氮平与利培酮治疗脑血管疾病所致精神障碍的对照研究[J].检验医学与临床，2011，8（22）：2765-2766.